Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Neuromodulation. 2021 Jul 12;25(4):569–577. doi: 10.1111/ner.13495

Table 4.

Estimated Marginal Means Post-hoc Comparisons

Comparison Estimate SE df t-value p-value
Within-group Val66Val
 Val66Val Baseline - Val66Val Post0 0.6711 0.0706 2855.3 9.499 <.0001
 Val66Val Baseline - Val66Val Post10 0.8394 0.0717 2855.1 11.714 <.0001
 Val66Val Baseline - Val66Val Post20 0.5644 0.0744 2856.4 7.582 <.0001
 Val66Val Baseline - Val66Val Post30 0.4423 0.0743 2856.5 5.953 <.0001
Within-group Val66Met
Val66Met Baseline - Val66Met Post0 −0.0479 0.0690 2858.8 −0.695 0.9995
Val66Met Baseline - Val66Met Post10 −0.0603 0.0685 2858.8 −0.880 0.9970
Val66Met Baseline - Val66Met Post20 0.0521 0.0679 2858.8 0.767 0.9990
 Val66Met Baseline - Val66Met Post30 0.4061 0.0650 2855.2 6.249 <.0001
Cross-group at same times
Val66Val Baseline - Val66Met Baseline 0.1875 0.3442 23.2 0.545 0.5911
Val66Val Post0 - Val66Met Post0 −0.5315 0.3451 23.5 −1.540 0.1370
Val66Val Post10 - Val66Met Post10 −0.7122 0.3453 23.5 −2.062 0.0504
Val66Val Post20 - Val66Met Post20 −0.3248 0.3459 23.7 −0.939 0.3571
Val66Met Post30 - Val66Met Post30 0.1514 0.3453 23.5 0.438 0.6651

Note: Significant differences in MEP amplitudes for Val66Val and Val66Met carriers are highlighted in bold. Estimate = difference in model-estimated MEPs from Baseline to Post-cTBS time points within each BDNF genotype group (Val66Val and Val66Met); SE = standard error of the estimate; df = degrees of freedom. Statistical test results represent Tukey-adjusted values correcting for multiple comparisons within the family of estimates compared.